Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic intravenous tranexamic acid for blood loss reduction in abdominal myomectomy
PACTR202610825805317Recruiting
- Sponsor
- Dr Nimi Ngo Briggs
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tranexamic acid in Fibromyoma (LM) (2 arms), sponsored by Dr Nimi Ngo Briggs. Primary endpoint: Perioperative blood loss. Started Sep 2024; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202610825805317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610825805317.